相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Systematic Review and Meta-Analysis of Vancomycin-Induced Nephrotoxicity Associated with Dosing Schedules That Maintain Troughs between 15 and 20 Milligrams per Liter
S. J. van Hal et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Vancomycin AUC/MIC Ratio and 30-Day Mortality in Patients with Staphylococcus aureus Bacteremia
Natasha E. Holmes et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
The emerging problem of linezolid-resistant Staphylococcus
Bing Gu et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2013)
The use of ceftaroline fosamil in methicillin-resistant Staphylococcus aureus endocarditis and deep-seated MRSA infections: a retrospective case series of 10 patients
Jennifer C. Lin et al.
JOURNAL OF INFECTION AND CHEMOTHERAPY (2013)
Implementation of an Antimicrobial Stewardship Pathway with Daptomycin for Optimal Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia
Ravina Kullar et al.
PHARMACOTHERAPY (2013)
Vancomycin AUC24/MIC Ratio in Patients with Complicated Bacteremia and Infective Endocarditis Due to Methicillin-Resistant Staphylococcus aureus and Its Association with Attributable Mortality during Hospitalization
Jack Brown et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Effect of Reduced Vancomycin Susceptibility on Clinical and Economic Outcomes in Staphylococcus aureus Bacteremia
Jennifer H. Han et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Daptomycin Versus Vancomycin for Bloodstream Infections Due to Methicillin-Resistant Staphylococcus aureus With a High Vancomycin Minimum Inhibitory Concentration: A Case-Control Study
Carol L. Moore et al.
CLINICAL INFECTIOUS DISEASES (2012)
Questionable Superiority of Linezolid for Methicillin-Resistant Staphylococcus aureus Nosocomial Pneumonia: Watch Where You Step
Timothy Lahey
CLINICAL INFECTIOUS DISEASES (2012)
Linezolid for the Treatment of Nosocomial Pneumonia Due to Methicillin-Resistant Staphylococcus aureus
Michel Wolff et al.
CLINICAL INFECTIOUS DISEASES (2012)
Methicillin-Resistant Staphylococcus aureus (MRSA) Staphylococcal Cassette Chromosome mec Genotype Effects Outcomes of Patients With Healthcare-Associated MRSA Bacteremia Independently of Vancomycin Minimum Inhibitory Concentration
Shey-Ying Chen et al.
CLINICAL INFECTIOUS DISEASES (2012)
The Clinical Significance of Vancomycin Minimum Inhibitory Concentration in Staphylococcus aureus Infections: A Systematic Review and Meta-analysis
S. J. van Hal et al.
CLINICAL INFECTIOUS DISEASES (2012)
Linezolid in Methicillin-Resistant Staphylococcus aureus Nosocomial Pneumonia: A Randomized, Controlled Study
Richard G. Wunderink et al.
CLINICAL INFECTIOUS DISEASES (2012)
Predictors of Mortality in Staphylococcus aureus Bacteremia
Sebastian J. van Hal et al.
CLINICAL MICROBIOLOGY REVIEWS (2012)
High vancomycin minimum inhibitory concentration is a predictor of mortality in meticillin-resistant Staphylococcus aureus bacteraemia
Yu Mi Wi et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2012)
Vancomycin MICs do not predict the outcome of methicillin-resistant Staphylococcus aureus bloodstream infections in correctly treated patients
Loreto Rojas et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Methicillin-resistant Staphylococcus aureus bacteraemia and endocarditis treated with ceftaroline salvage therapy
Tony T. Ho et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Is Vancomycin MIC Creep Method Dependent? Analysis of Methicillin-Resistant Staphylococcus aureus Susceptibility Trends in Blood Isolates from North East Scotland from 2006 to 2010
B. Edwards et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2012)
Serine/Threonine Phosphatase Stp1 Contributes to Reduced Susceptibility to Vancomycin and Virulence in Staphylococcus aureus
David R. Cameron et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
Impact of vancomycin MIC creep on patients with methicillin-resistant Staphylococcus aureus bacteremia
Yen-Cheng Yeh et al.
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2012)
Characteristics and Outcomes of Methicillin-Resistant Staphylococcus aureus Bloodstream Infections in Patients with Cancer Treated with Vancomycin: 9-Year Experience at a Comprehensive Cancer Center
Sminil N. Mahajan et al.
ONCOLOGIST (2012)
Systematic Review and Meta-Analysis of the Significance of Heterogeneous Vancomycin-Intermediate Staphylococcus aureus Isolates
Sebastiaan J. van Hal et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
The Interface Between Antibiotic Resistance and Virulence in Staphylococcus aureus and Its Impact Upon Clinical Outcomes
David R. Cameron et al.
CLINICAL INFECTIOUS DISEASES (2011)
Vancomycin: We Can't Get There from Here
Nimish Patel et al.
CLINICAL INFECTIOUS DISEASES (2011)
Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus Aureus Infections in Adults and Children
Catherine Liu et al.
CLINICAL INFECTIOUS DISEASES (2011)
Impact of Vancomycin Exposure on Outcomes in Patients with Methicillin-Resistant Staphylococcus aureus Bacteremia: Support for Consensus Guidelines Suggested Targets
Ravina Kullar et al.
CLINICAL INFECTIOUS DISEASES (2011)
Prevalence of antimicrobial resistant pathogens from blood cultures from Canadian hospitals: results of the CANWARD 2007-2009 study
Heather J. Adam et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2011)
Emergence of daptomycin resistance following vancomycin-unresponsive Staphylococcus aureus bacteraemia in a daptomycin-naive patient-a review of the literature
S. J. van Hal et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2011)
Vancomycin-associated nephrotoxicity: a critical appraisal of risk with high-dose therapy
Annie Wong-Beringer et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2011)
Methicillin-resistant Staphylococcus aureus vancomycin susceptibility testing: methodology correlations, temporal trends and clonal patterns
Sebastiaan J. van Hal et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Site of infection rather than vancomycin MIC predicts vancomycin treatment failure in methicillin-resistant Staphylococcus aureus bacteraemia
Carla J. Walraven et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Vancomycin Susceptibility Trends and Prevalence of Heterogeneous Vancomycin-Intermediate Staphylococcus aureus in Clinical Methicillin-Resistant S. aureus Isolates
Adam M. Pitz et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2011)
Performance of Various Testing Methodologies for Detection of Heteroresistant Vancomycin-Intermediate Staphylococcus aureus in Bloodstream Isolates
Sebastian J. van Hal et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2011)
Antibiotic Choice May Not Explain Poorer Outcomes in Patients With Staphylococcus aureus Bacteremia and High Vancomycin Minimum Inhibitory Concentrations
Natasha E. Holmes et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Epidemiology of Methicillin-Resistant Staphylococcus aureus (MRSA) Bloodstream Infection Secular Trends Over 19 Years at a University Hospital
Oriol Gasch et al.
MEDICINE (2011)
Vancomycin Heteroresistance Is Associated with Reduced Mortality in ST239 Methicillin-Resistant Staphylococcus aureus Blood Stream Infections
Sebastiaan J. van Hal et al.
PLOS ONE (2011)
Detection and Characterization of Heterogeneous Vancomycin-Intermediate Staphylococcus aureus Isolates in Canada: Results from the Canadian Nosocomial Infection Surveillance Program, 1995-2006
Heather J. Adam et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Clinical, microbiologic, and genetic determinants of persistent methicillin-resistant Staphylococcus aureus bacteremia
Elizabeth A. Neuner et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2010)
Clinical Outbreak of Linezolid-Resistant Staphylococcus aureus in an Intensive Care Unit
Miguel Sanchez Garcia et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Vancomycin MIC creep in MRSA isolates from 1997 to 2008 in a healthcare region in Hong Kong
Pak-Leung Ho et al.
JOURNAL OF INFECTION (2010)
Vancomycin MIC Susceptibility Testing of Methicillin-Susceptible and Methicillin-Resistant Staphylococcus aureus Isolates: A Comparison Between Etest® and an Automated Testing Method
Christopher M. Bland et al.
SOUTHERN MEDICAL JOURNAL (2010)
Evaluation of Vancomycin and Daptomycin Potency Trends (MIC Creep) against Methicillin-Resistant Staphylococcus aureus Isolates Collected in Nine US Medical Centers from 2002 to 2006
Helio S. Sader et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Prospective Comparison of the Clinical Impacts of Heterogeneous Vancomycin-Intermediate Methicillin-Resistant Staphylococcus aureus (MRSA) and Vancomycin-Susceptible MRSA
K. C. Horne et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Vancomycin Therapeutic Guidelines: A Summary of Consensus Recommendations from the Infectious Diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists
Michael J. Rybak et al.
CLINICAL INFECTIOUS DISEASES (2009)
Relationship between Initial Vancomycin Concentration-Time Profile and Nephrotoxicity among Hospitalized Patients
Thomas P. Lodise et al.
CLINICAL INFECTIOUS DISEASES (2009)
Vancomycin MIC plus Heteroresistance and Outcome of Methicillin-Resistant Staphylococcus aureus Bacteremia: Trends over 11 Years
Adina C. Musta et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2009)
Susceptibility relationship between vancomycin and daptomycin in Staphylococcus aureus: facts and assumptions
Pamela A. Moise et al.
LANCET INFECTIOUS DISEASES (2009)
Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia
Alex Soriano et al.
CLINICAL INFECTIOUS DISEASES (2008)
Increasing antibiotic resistance among methicillin-resistant Staphylococcus aureus strains
George Sakoulas et al.
CLINICAL INFECTIOUS DISEASES (2008)
High rate of decreasing daptomycin susceptibility during the treatment of persistent Staphylococcus aureus bacteremia
M. Sharma et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2008)
Vancomycin MICs did not creep in Staphylococcus aureus isolates from 2002 to 2006 in a setting with low vancomycin usage
Juan-Ignacio Alos et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Characterization of vancomycin-heteroresistant Staphylococcus aureus from the metropolitan area of Detroit, Michigan, over a 22-year period (1986 to 2007)
Michael J. Rybak et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2008)
Inhibitory activities of 11 antimicrobial agents and bactericidal activities of vancomycin an dantomycin against invasive methicillin-resistant Staphylococcus aureus isolates obtained from 1999 through 2006
Robert L. Holmes et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Outcome of vancomycin treatment in patients with methicillin-susceptible Staphylococcus aureus bacteremia
Sung-Han Kim et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S-aureus (MRSA) blood isolates from 2001-05
Gregory Steinkraus et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Point:: Vancomycin is not obsolete for the treatment of infection caused by methicillin-resistant Staphylococcus aureus
John F. Mohr et al.
CLINICAL INFECTIOUS DISEASES (2007)
Counterpoint:: Vancomycin and Staphylococcus aureus -: An antibiotic enters obsolescence
Stan Deresinski
CLINICAL INFECTIOUS DISEASES (2007)
Use of vancomycin or first-generation cephalosporins for the treatment of hemodialysis-dependent patients with methicillin-susceptible Staphylococcus aureus bacteremia
Martin E. Stryjewski et al.
CLINICAL INFECTIOUS DISEASES (2007)
Increased vancomycin MICs for Staphylococcus aureus clinical isolates from a university hospital during a 5-year period
Guiqing Wang et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2006)
Predictors of mortality for methicillin-resistant Staphylococcus aureus health-care-associated pneumonia -: Specific evaluation of vancomycin pharmacokinetic indices
Meghan N. Jeffres et al.
CHEST (2006)
Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus
Vance G. Fowler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
The future should not look like the past
[Anonymous]
LANCET INFECTIOUS DISEASES (2006)
Decreased susceptibility to glycopeptides in methicillin-resistant Staphylococcus aureus:: a 20 year study in a large French teaching hospital, 1983-2002
J Robert et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Microbiological features of vancomycin in the 21st century: Minimum inhibitory concentration creep, bactericidal/static activity, and applied breakpoints to predict clinical outcomes or detect resistant strains
RN Jones
CLINICAL INFECTIOUS DISEASES (2006)
Antimicrobial pharmacodynamics: Critical interactions of 'bug and drug'
GL Drusano
NATURE REVIEWS MICROBIOLOGY (2004)
Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections
PA Moise-Broder et al.
CLINICAL PHARMACOKINETICS (2004)
分享论文
